GFI Europe recently published its 2026 Mid-Year Impact Update, highlighting progress across policy, science, and industry during the first half of the year. The update covers work to generate evidence for policymakers, connect researchers and companies to solve technical bottlenecks, and support businesses as they scale alternative proteins across Europe.
Food biomanufacturing and national security
GFI and the National Defense Industrial Association’s Emerging Technologies Institute published a new research brief examining the national security implications of food biomanufacturing. The brief was launched at a Washington, D.C. convening attended by food biomanufacturing companies and representatives from 11 U.S. federal offices, followed by meetings with congressional offices.
The report argues that food biomanufacturing can strengthen domestic supply chains, reduce dependence on vulnerable agricultural inputs, and position alternative proteins within broader U.S. biotechnology and manufacturing priorities.
Open-access roadmap for cultivated seafood research
GFI published Developing Continuous Cell Lines for Cultivated Seafood, a new technical guide to help researchers establish continuous cell lines for fish and crustaceans. Developed with scientists from across the field, the guide brings together practical recommendations and troubleshooting advice in a single open-access resource.
Reliable cell lines remain a key technical bottleneck for cultivated seafood. By making this knowledge openly available, GFI aims to reduce duplicated effort and lower barriers for new researchers entering the field.
First novel mycoprotein authorised in the EU
The European Commission has authorised The Protein Brewery’s Fermotein under the EU Novel Food Regulation, making it the first newly authorised mycoprotein that can now be sold across all 27 EU Member States.
This is an important milestone for alternative proteins in Europe and may help establish regulatory precedent for future mycoprotein applications.
The Good Food Institute Organisation Updates:
GFI Europe Mid-Year Impact Update
GFI Europe recently published its 2026 Mid-Year Impact Update, highlighting progress across policy, science, and industry during the first half of the year. The update covers work to generate evidence for policymakers, connect researchers and companies to solve technical bottlenecks, and support businesses as they scale alternative proteins across Europe.
Food biomanufacturing and national security
GFI and the National Defense Industrial Association’s Emerging Technologies Institute published a new research brief examining the national security implications of food biomanufacturing. The brief was launched at a Washington, D.C. convening attended by food biomanufacturing companies and representatives from 11 U.S. federal offices, followed by meetings with congressional offices.
The report argues that food biomanufacturing can strengthen domestic supply chains, reduce dependence on vulnerable agricultural inputs, and position alternative proteins within broader U.S. biotechnology and manufacturing priorities.
Open-access roadmap for cultivated seafood research
GFI published Developing Continuous Cell Lines for Cultivated Seafood, a new technical guide to help researchers establish continuous cell lines for fish and crustaceans. Developed with scientists from across the field, the guide brings together practical recommendations and troubleshooting advice in a single open-access resource.
Reliable cell lines remain a key technical bottleneck for cultivated seafood. By making this knowledge openly available, GFI aims to reduce duplicated effort and lower barriers for new researchers entering the field.
First novel mycoprotein authorised in the EU
The European Commission has authorised The Protein Brewery’s Fermotein under the EU Novel Food Regulation, making it the first newly authorised mycoprotein that can now be sold across all 27 EU Member States.
This is an important milestone for alternative proteins in Europe and may help establish regulatory precedent for future mycoprotein applications.
We’re hiring:
Lead SciTech Specialist, GFI APAC (Remote—Korea) – Apply by 19 July 2026
Sector Development Strategist, GFI APAC (APAC Region) – No deadline – applications will be reviewed on a rolling basis.
Thanks for reading.